BRCA1 and ovarian carcinoma: The results are consistent with findings from a previous CIMBA study, based on fewer samples and fewer SNPs, which demonstrated that PRS can lead to large differences in absolute risks of developing breast and ovarian cancers for female BRCA1/2 carriers.10